Bladder Perfusion of Plasma-Activated Saline for Bladder Cancer

Summary

This preliminary clinical study evaluates the safety and initial efficacy of a novel therapy called Plasma-Activated Saline Solution (PASS) for bladder cancer patients. The study involves a one-week course of PASS administered via bladder infusion in five pre-surgical patients, using imaging and pathology analyses to assess tumor shrinkage and cancer cell death, while closely monitoring for any adverse reactions to explore the therapy's future potential.

Timeline

Start

2025-12-15

Primary completion

2026-02-15

Completion

2026-02-15

Drugs

Indications